Anzeige
Mehr »
Login
Mittwoch, 24.04.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Breaking News: InnoCan startet in eine neue Ära – FDA Zulassung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
116 Leser
Artikel bewerten:
(0)

Global Flow Cytometer Market 2017-2021 - Market to Grow at a CAGR of 10.16%

DUBLIN, September 15, 2017 /PRNewswire/ --

The "Global Flow Cytometer Market 2017-2021" report has been added to Research and Markets' offering.

Research and Markets Logo

The global flow cytometer market to grow at a CAGR of 10.16% during the period 2017-2021.

The report covers the present scenario and the growth prospects of the global flow cytometer market for 2017-2021. To calculate the market size, the report the considers revenue generated by the sales of instruments, reagents, and services provided for flow cytometry. The report also includes a discussion of the key vendors operating in this market.

One trend in the market is increasing level of process automation. Automation is evident in nearly all laboratory processes, including flow cytometry. From using manual sample preparation and loading techniques earlier to now using instruments that are designed to prepare, load, and store samples for the process, the technology and level of automation have improved greatly over the past couple of decades.

According to the report, one driver in the market is increasing expenditure on R&D. The global expenditure on R&D has seen steady growth over the last 10 years. It went up from $522 billion in 1996 to $1.3 trillion in 2009. In 2016, it was worth an estimated $1.9 trillion. With the economies of developing countries growing faster than those of developed ones, the former are likely to see an increase in the number of research facilities and institutes over the next five years. This growth in infrastructural facilities will, in turn, lead to a rise in demand for flow cytometer instruments and other commonly used laboratory analysis equipment.

Further, the report states that one challenge in the market is shortage of skilled professionals. Flow cytometer instruments are often large and complex and require sophisticated analysis software for various measurement procedures. This means that the operation of these instruments and the analysis of samples will require the user to gain considerable training. Therefore, companies need to invest heavily in providing training to their employees on how to use these instruments effectively. The limited number of such trained professionals is posing challenges to the growth of the market and will likely continue to do so during the forecast period.

Key vendors

  • BD
  • Beckman Coulter
  • Luminex
  • EMD Millipore
  • Thermo Fisher Scientific

Other prominent vendors

  • Advanced Analytical Technologies
  • Apogee Flow Systems
  • Bio-Rad Laboratories
  • Cytek Biosciences
  • Cytonome
  • Miltenyi Biotec
  • Mindray Medical International
  • Sysmex Partec
  • Sony Biotechnology
  • Stratedigm
  • TTP Labtech

Key Topics Covered:

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Introduction

Part 05: Market Landscape

Part 06: Market Segmentation By Product

Part 07: Market Segmentation By End-User

Part 08: Geographical Segmentation

Part 09: Decision Framework

Part 10: Drivers And Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Key Vendor Analysis

For more information about this report visit https://www.researchandmarkets.com/research/nxwlmv/global_flow

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.